Sickle Pan-African Research Consortium (SPARCO)- Tanzania
Sickle 泛非研究联盟 (SPARCO) - 坦桑尼亚
基本信息
- 批准号:10625454
- 负责人:
- 金额:$ 26.93万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-05-15 至 2026-04-30
- 项目状态:未结题
- 来源:
- 关键词:APOL1 geneAddressAdoptionAdvocacyAffectAfricaAfrica South of the SaharaAfricanAgeAmerican Society of HematologyAreaAuthorization documentationBirthCaringCellsClinicClinicalClinical ManagementClinical ResearchCohort StudiesCollaborationsCollectionCommunicationComprehensive Health CareConsentCountryCreatinineDataData AnalysesData Coordinating CenterDatabasesDevelopmentDiseaseDisease ManagementDistrict HospitalsDoctor of PhilosophyEducational process of instructingEffectivenessEffectiveness of InterventionsElementsEnrollmentEssential DrugsEventFailureFellowshipFellowship ProgramFetal HemoglobinFetal KidneyFundingGeneticGhanaGoalsGrantGrowthGuidelinesHIV/TBHaplotypesHealthHealth PersonnelHealth systemHealthcareHematologyHomeHospital Information SystemsHospitalsHuman ResourcesImmunizationIndividualInfectionInternationalInterventionInvestigationLaboratoriesLinkMalariaMendelian disorderMorbidity - disease rateNational Heart, Lung, and Blood InstituteNeonatal ScreeningNewborn InfantNigeriaOntologyOrganPatient EducationPatientsPhenotypePoliciesPostdoctoral FellowProphylactic treatmentProteinsPyrimethamineReadinessRecommendationReportingResearchResearch PersonnelResearch TrainingRiskSerumSickle Cell AnemiaSiteSocietiesStructureStudentsTanzaniaTherapeutic InterventionTrainingTraining ProgramsTranslationsUnited States National Institutes of HealthUrineVariantVisitWorkZanzibarauthoritybig data managementclinical carecohortdata infrastructuredesigneffective interventionelectronic dataevidence baseexperiencefollow-upgenetic varianthealth traininghydroxyureaimmune activationimplementation researchimprovedkidney dysfunctionmeetingsmembermortalityoperationpreventive interventionprogramsscale upscreeningscreening programshared databasesicklingskillsstandard of caresuccesstertiary caretreatment program
项目摘要
PROJECT SUMMARY
The burden of sickle cell disease (SCD) is highest in sub-Saharan Africa (SSA) where over 75% of patients
currently reside. Tanzania is one of the countries most affected by the disease with an estimated 11,000 births
a year, the 5th highest in the world. Major challenges in addressing the burden of SCD in SSA have been the
lack of multi-site, well described cohorts of SCD patients; failure to deploy consistent standards of care; human
resource capacity that is limited in number and skills and limited research in areas pertinent to SCD in the African
context. In 2017 three SSA countries, Tanzania, Ghana and Nigeria, teamed up to establish the Sickle
Pan-African Research Consortium (SPARCO) to address these challenges. Building on successes achieved to
date, SPARCO-Tanzania aims to expand as the Center of Excellence in Training and Research in SCD with the
long term goal to advance the care for SCD and contribute to the consortium in generating evidence that will
inform the deployment of effective interventions in SSA. Specifically, SPARCO-Tanzania aims to 1) Enhance
communication and collaboration with members of the SCD in SSA Network to engage in continent-wide
research and create a “Policy Translation Group” that will embed evidence-based best practices in national
policy, 2) Increase the quantity and quality of data in the SPARCO database by i) increasing the number of
enrolled SCD patients to 7,000 by integrating a new satellite site in Zanzibar and implementing newborn
screening (NBS) across the country, (in collaboration with the America Society of Hematology); ii) using SMS
reminders and age-specific patient educational programs to boost clinic attendance at follow-up visits to collect
longitudinal data; 3) Enhance the utilization of the customized multi-level SCD Standards of Care (SoC) in the
Tanzanian health system by engaging with the Ministry of Health to promote the adoption and use of the SoC
from tertiary care level to home; 4) partner with existing programs in and outside the consortium to conduct
short, medium and long term training and fellowship programs on the clinical management and research on SCD
to strengthen skills in SCD care and research; and 5) Conduct cohort studies to improve understanding of
current status of the disease and risk-modifiers (specifically on the genetic variability in fetal hemoglobin and
kidney dysfunction and effect of Hydroxyurea on immune activation), and implementation research to evaluate
planned interventions (specifically the feasibility, acceptability and sustainability of NBS, Hydroxyurea usage
and malaria prophylaxis) aiming at elucidating best approaches to scale-up introduction of these preventive and
therapeutic interventions in the local context. Collectively, the project will increase the amount and quality of
data on SCD in SSA, enable growth of a critical mass of researchers and generate evidence that will inform
policy change which, concurrent with the growth in the standards of care, will lead to the reduction in the
morbidity and mortality due to SCD in SSA.
项目摘要
镰状细胞病(SCD)的负担在撒哈拉以南非洲(SSA)最高,超过75%的患者
目前居住。坦桑尼亚是受该疾病影响最严重的国家之一,估计有11,000名新生儿
一年,世界第五高。在撒哈拉以南非洲解决SCD负担的主要挑战是
缺乏多中心、描述良好的SCD患者队列;未能部署一致的护理标准;人类
资源能力在数量和技能方面有限,在非洲与可持续发展有关的领域的研究有限
上下文2017年,坦桑尼亚、加纳和尼日利亚这三个撒哈拉以南非洲国家联手建立了"镰刀"组织。
泛非研究联合会(SPARCO)致力于应对这些挑战。在取得的成功基础上,
截至目前,SPARCO-坦桑尼亚旨在扩大作为SCD培训和研究卓越中心的规模,
长期目标是促进SCD的治疗,并为联盟提供证据,
为在撒哈拉以南非洲部署有效干预措施提供信息。具体而言,SPARCO-坦桑尼亚的目标是:1)加强
与南亚区域网络中的SCD成员进行沟通和协作,
研究并创建一个"政策翻译小组",将以证据为基础的最佳做法纳入国家政策。
政策,2)通过i)增加SPARCO数据库中数据的数量和质量
通过在桑给巴尔整合一个新的卫星站点并实施新生儿
全国范围内的筛查(NBS),(与美国血液学会合作); ii)使用SMS
提醒和针对特定年龄的患者教育计划,以提高随访时的门诊出勤率,
纵向数据; 3)提高定制的多层次SCD护理标准(SoC)的利用率
坦桑尼亚卫生系统,与卫生部合作,促进采用和使用标准守则
从三级护理水平到家庭; 4)与联盟内外的现有项目合作,
SCD临床管理和研究的短期、中期和长期培训和奖学金计划
加强SCD护理和研究的技能;以及5)进行队列研究,以提高对
疾病的现状和风险修饰因素(特别是胎儿血红蛋白的遗传变异性,
肾功能不全和羟基脲对免疫激活的影响),并实施研究,以评估
计划的干预措施(特别是NBS的可行性、可接受性和可持续性,
和疟疾预防),旨在阐明扩大采用这些预防和
在当地进行治疗干预。总的来说,该项目将提高
关于SSA中SCD的数据,使研究人员的临界质量得以增长,并产生证据,
政策变化,与护理标准的提高同时,将导致
发病率和死亡率由于SCD在SSA。
项目成果
期刊论文数量(11)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Promoting access of hydroxyurea to sickle cell disease individuals: Time to make it an essential medicine.
- DOI:10.12688/f1000research.111300.1
- 发表时间:2022
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Nasopharyngeal Carriage and Antibiogram of Pneumococcal and Other Bacterial Pathogens from Children with Sickle Cell Disease in Tanzania.
坦桑尼亚镰状细胞病儿童的肺炎球菌和其他细菌病原体的鼻咽携带和抗菌谱。
- DOI:10.2147/idr.s367873
- 发表时间:2022
- 期刊:
- 影响因子:3.9
- 作者:Mutagonda, Ritah F.;Bwire, George;Sangeda, Raphael Zozimus;Kilonzi, Manase;Mlyuka, Hamu;Ndunguru, Joyce;Jonathan, Agnes;Makani, Julie;Minja, Irene Kida;Ruggajo, Paschal;Balandya, Emmanuel;Kamuhabwa, Appolinary A. R.
- 通讯作者:Kamuhabwa, Appolinary A. R.
Prevalence of Hemoglobin-S and Baseline Level of Knowledge on Sickle Cell Disease Among Pregnant Women Attending Antenatal Clinics in Dar-Es-Salaam, Tanzania.
- DOI:10.3389/fgene.2022.805709
- 发表时间:2022
- 期刊:
- 影响因子:3.7
- 作者:
- 通讯作者:
Outcomes of Hydroxyurea Accessed via Various Means and Barriers Affecting Its Usage Among Children with Sickle Cell Anaemia in North-Western Tanzania.
- DOI:10.2147/jbm.s380901
- 发表时间:2023
- 期刊:
- 影响因子:2
- 作者:
- 通讯作者:
The Effects of Sickle Cell Disease on the Quality of Life: A Focus on the Untold Experiences of Parents in Tanzania.
镰状细胞疾病对生活质量的影响:关注坦桑尼亚父母的无数经历。
- DOI:10.3390/ijerph19116871
- 发表时间:2022-06-04
- 期刊:
- 影响因子:0
- 作者:Kilonzi, Manase;Mwakawanga, Dorkasi L.;Felician, Fatuma Felix;Mlyuka, Hamu J.;Chirande, Lulu;Myemba, David T.;Sambayi, Godfrey;Mutagonda, Ritah F.;Mikomangwa, Wigilya P.;Ndunguru, Joyce;Jonathan, Agnes;Ruggajo, Paschal;Minja, Irene Kida;Balandya, Emmanuel;Makani, Julie;Sirili, Nathanael
- 通讯作者:Sirili, Nathanael
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
EMMANUEL BALANDYA其他文献
EMMANUEL BALANDYA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('EMMANUEL BALANDYA', 18)}}的其他基金
Sickle Pan-African Research Consortium (SPARCO)- Tanzania
Sickle 泛非研究联盟 (SPARCO) - 坦桑尼亚
- 批准号:
10176620 - 财政年份:2021
- 资助金额:
$ 26.93万 - 项目类别:
Sickle Pan-African Research Consortium (SPARCO)- Tanzania
Sickle 泛非研究联盟 (SPARCO) - 坦桑尼亚
- 批准号:
10404083 - 财政年份:2021
- 资助金额:
$ 26.93万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 26.93万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 26.93万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 26.93万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 26.93万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 26.93万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 26.93万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 26.93万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 26.93万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 26.93万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 26.93万 - 项目类别:
Research Grant